DICE Therapeutics to Participate at Upcoming Investor
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- DICE Therapeutics, Inc. (Nasdaq: DICE), a
Globe Newswire9-02-2023, 04:09
VAST Data Closes Series E Funding Round, Nearly Triples Valuation to $9.1 Billion 6-12-2023, 23:26